Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.440
+0.020 (1.41%)
At close: Jan 15, 2026, 4:00 PM EST
1.440
0.00 (0.00%)
Pre-market: Jan 16, 2026, 6:06 AM EST
Autolus Therapeutics Market Cap
Autolus Therapeutics has a market cap or net worth of $383.25 million as of January 16, 2026. Its market cap has decreased by -34.84% in one year.
Market Cap
383.25M
Enterprise Value
341.01M
1-Year Change
-34.84%
Ranking
Category
Stock Price
$1.44
Market Cap Chart
Since June 22, 2018, Autolus Therapeutics's market cap has decreased from $969.66M to $383.25M, a decrease of -60.48%. That is a compound annual growth rate of -11.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 383.25M | -27.64% |
| Dec 31, 2025 | 529.63M | -15.31% |
| Dec 31, 2024 | 625.39M | -44.17% |
| Dec 29, 2023 | 1.12B | 240.67% |
| Dec 30, 2022 | 328.81M | -13.12% |
| Dec 31, 2021 | 378.45M | -19.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 22, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 924.90B |
| Johnson & Johnson | 529.01B |
| AbbVie | 383.08B |
| UnitedHealth Group | 307.04B |
| AstraZeneca | 291.28B |
| Merck & Co. | 275.43B |
| Novartis AG | 273.64B |
| Novo Nordisk | 252.12B |